Eli Lilly Drops Despite Positive Lung Cancer Drug Data

The equity is trading near a recent level of resistance

Digital Content Manager
Sep 9, 2019 at 9:41 AM
facebook X logo linkedin

The shares of Eli Lilly and Co (NYSE:LLY) are down 0.5% at $113.53 this morning, even after data from a recent study showed the pharmaceutical giant's experimental drug LOXO-292 shrank tumors in nearly 70% of patients suffering from advanced lung cancer. The firm plans on applying for U.S. marketing approval by the end of 2019.

Today's drop has LLY stock retreating from its 120-day moving average, which also happens to reside in the $116 region -- an area the stock hasn't closed north of since an early June bear gap. Since hitting a year-to-date low of $105.14 in mid-July, though, the equity has gained 10% atop support its rising 320-day moving average.

The majority of analysts have held out hope for LLY, with seven in coverage calling it a "strong buy," compared to four that have given it a tepid "hold" rating. On the other hand, Eli Lilly's consensus 12-moth target price of $123.83 is at a relatively slim 8% premium to current levels. 

Options traders, however, have been more bearish. LLY sports a 10-day put/call volume ratio of 1.32 on the the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX). This ratio sits in the 88th percentile of its annual range, hinting at a bigger appetite for long puts over calls of late.


Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI